Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Evaluating 5-aminosalicylic acid (5ASA) efficacy in treatment of symptomatic hemorrhoids
IRCT20191226045897N2Phase 3Completed
- Sponsor
- Babol University of Medical Sciences
- Start
- Apr 2021
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 3 trial of Salcrozine in hemorrhoid, sponsored by Babol University of Medical Sciences. Started Apr 2021; status: completed.
02
Drugs
Salcrozine
03
Conditions
hemorrhoid
Beyond the preview
Go deeper on IRCT20191226045897N2.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on IRCT20191226045897N2.